Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative

Lin-Hao You1, Zhen Li1, Xiang-Lin Duan1

  • 1Laboratory of Molecular Iron Metabolism, College of Life Science, Hebei Normal University, Shijiazhuang 050016, Hebei Province, China.

Brain Research
|March 29, 2016
PubMed

Insights

Mitochondrial ferritin (MtFt) protects against MPTP-induced Parkinson's disease by reducing iron accumulation and oxidative stress, preserving neuronal integrity.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial ferritin (MtFt) is known to protect against 6-OHDA-induced Parkinson's disease (PD).
  • The role of MtFt in MPTP-induced PD models remains unclear.
  • MPTP is a common neurotoxin used to model Parkinson's disease.

Purpose of the Study:

  • To investigate the role of mitochondrial ferritin (MtFt) in methyl-4-phenyl-1, 2, 3, 6-tetra-pyridine (MPTP)-induced Parkinson's disease (PD).
  • To determine the protective mechanisms of MtFt against MPTP-induced neurotoxicity.

Main Methods:

  • MPTP was used to induce a PD model in mice.
  • Mitochondrial ferritin knockout (MtFt-/-) mice and MtFt-overexpressing cells were utilized.
  • Expression levels of TfR1, tyrosine hydroxylase, L-ferritin, Bcl2/Bax ratio, and ferroportin 1 were analyzed.
  • Mitochondrial membrane potential, labile iron pool, reactive oxygen species, and apoptosis were assessed.

Main Results:

  • MPTP upregulated MtFt expression in mouse brain regions (hippocampus, substantia nigra, striatum).
  • MPTP downregulated TfR1 and tyrosine hydroxylase, while upregulating L-ferritin.
  • MtFt deficiency exacerbated MPTP-induced neuronal damage, indicated by a decreased Bcl2/Bax ratio.
  • MtFt overexpression protected against MPP+-induced mitochondrial damage, reduced oxidative stress, and inhibited apoptosis.

Conclusions:

  • Mitochondrial ferritin plays a crucial protective role in MPTP-induced Parkinson's disease.
  • MtFt mitigates neurotoxicity by inhibiting cellular iron accumulation and subsequent oxidative stress.
  • These findings highlight MtFt as a potential therapeutic target for Parkinson's disease.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.7K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.3K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.2K